Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Misselwitz

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
The American Journal of Clinical Nutrition|March 19, 2021
Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomesYawen Zhang, Lijun Feng, Xin Wang, et al.
Journal of Crohn'S & Colitis|December 12, 2018
Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel DiseaseIrina Tcymbarevich, Shola M Richards, Giancarlo Russo, et al.
Mucosal Immunology|February 12, 2019
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitisAnnika Wyss, Tina Raselli, Nathan Perkins, et al.
Journal of Crohn'S & Colitis|August 31, 2018
Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to FibrogenesisSenta Hutter, Wouter T van Haaften, Anouk Hünerwadel, et al.
Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel diseaseSimon Woelfel, Joel Dütschler, Marius König, et al.
The Journal of Experimental Medicine|May 26, 2018
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activityClaus Kadelka, Thomas Liechti, Hanna Ebner, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF TreatmentThomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
BMC Pediatrics|November 10, 2023
The Bern Birth Cohort (BeBiCo) to study the development of the infant intestinal microbiota in a high-resource setting in Switzerland: rationale, design, and methodsLuca Cecchini, Colette Barmaz, Maria José Coloma Cea, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
The American Journal of Clinical Nutrition|March 19, 2021
Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomesYawen Zhang, Lijun Feng, Xin Wang, et al.
Journal of Crohn'S & Colitis|December 12, 2018
Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel DiseaseIrina Tcymbarevich, Shola M Richards, Giancarlo Russo, et al.
Mucosal Immunology|February 12, 2019
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitisAnnika Wyss, Tina Raselli, Nathan Perkins, et al.
Journal of Crohn'S & Colitis|August 31, 2018
Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to FibrogenesisSenta Hutter, Wouter T van Haaften, Anouk Hünerwadel, et al.
Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel diseaseSimon Woelfel, Joel Dütschler, Marius König, et al.
The Journal of Experimental Medicine|May 26, 2018
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activityClaus Kadelka, Thomas Liechti, Hanna Ebner, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF TreatmentThomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
BMC Pediatrics|November 10, 2023
The Bern Birth Cohort (BeBiCo) to study the development of the infant intestinal microbiota in a high-resource setting in Switzerland: rationale, design, and methodsLuca Cecchini, Colette Barmaz, Maria José Coloma Cea, et al.
Pageof 16